News

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
"The Economist": Five stories that will change the world in 2023 – Psychedelic medicine
There are three psychedelic drugs already in the advanced stages of clinical trials for the treatment of mental health that could become part of our prescriptions. One of them is ketamine.
27/12/2022
"BBC": Clinical trial of ketamine for alcohol dependence moves to the next phase in the United Kingdom
The clinical trial led by the University of Exeter and Awakn Life Sciences, with funding of 2.4 million pounds, will take place in seven NHS centers across the UK.
13/12/2022
"The Economist": Ketamine, psilocybin, and ecstasy are making their way into the medicine cabinet.
From expanding minds to healing brains.
21/09/2022
"The New Yorker": Ketamine therapy is becoming mainstream. Are we ready?
The drug with psychedelic properties has been proven to work for people suffering from anxiety and depression.
29/12/2021
"The Guardian": Ketamine revolutionized my mind
This week sees the opening of the UK's first private clinic providing psychedelic-assisted psychotherapy. Could these drugs be the future of mental health treatments?
13/03/2021
"Forbes": New York University Establishes Center for Psychedelic Medicine
The scientists and doctors will continue their communication work with the support of 10 million dollars from MindMed and philanthropists.
25/02/2021